Offer patients Pelargonium sidoides (30 drops 3 times a day) to reduce the severity and duration of common cold symptoms and to get patients back to work sooner.1
Strength of recommendation
B: A single well-designed randomized controlled trial
Lizogub VG, Riley DS, Heger M. Efficacy of a Pelargonium sidoides preparation in patients with the common cold: A randomized, double blind, placebo-controlled clinical trial. Explore (NY) 2007; 3:573–584.
ILLUSTRATIVE CASE
A 39-year-old, otherwise healthy woman presents to your clinic with a sore throat, nasal congestion, and dry cough she’s had since yesterday. She wants an antibiotic, but your evaluation reveals an uncomplicated viral upper respiratory infection—a common cold. You would like to provide her with an alternative treatment, but you are aware of the lack of evidence for clear benefit of zinc lozenges, echinacea, and vitamin C. Is there any other medication that might benefit this patient?
Yes. Pelargonium sidoides, a species of South African geranium used for centuries in Zulu medicine,2 shows promise as an herbal remedy for respiratory infections. Two randomized trials show that extracts of P sidoides improve symptoms of acute bronchitis which, like the common cold, is usually caused by a virus.3-5
There is a plausible biological mechanism of action. In vitro studies show that Pelargonium extract induces the interferon system and up-regulates cytokines important in protecting host cells from viral infection.6
BACKGROUND: $17 billion dollar cold
Our patients want more relief from cold symptoms and are clearly willing to pay for it. Americans spend approximately $2.9 billion annually on over-the-counter (OTC) cold preparations and $1.1 billion on unnecessary antibiotics.7 The term “common cold” refers to a collection of symptoms, including sore throat, rhinorrhea, nasal congestion, cough, low-grade fever, and malaise, usually self-limited and lasting 10 to 14 days, caused by a number of viruses, most commonly by a rhinovirus.8 According to the 2005 National Ambulatory Medical Care Survey, the common cold is the third most common diagnosis in physicians’ offices behind only hypertension and well-infant/child visits.9 A 2001 US telephone survey determined that approximately 500 million episodes of non-influenza viral infection occur annually, resulting in direct costs of $17 billion for physician services and medications and approximately 200 million missed days of work.7
CLINICAL CONTEXT: Evidence proves most cold remedies don’t work
Although colds are common and result in annoying symptoms and missed work, much of the money spent on remedies is wasted. A truly effective treatment would be valuable to our patients.
Despite brisk sales, evidence for the efficacy of various cold remedies is inconclusive and contradictory. We found 6 Cochrane reviews of cold treatments, including antitussives, antihistamines, decongestants, vitamin C, echinacea, and zinc lozenges. With the exception of pseudoephedrine for nasal symptoms, the evidence that any product improves symptoms or decreases the duration of the cold is not encouraging.
Cough medications. The 2004 Cochrane Review of OTC medications for cough10 found no consistent evidence that any of them work. Codeine was no more effective than placebo for reducing cough symptoms. Three efficacy studies of dextromethorphan for cough showed either no difference or small but possibly clinically insignificant improvement in cough over placebo. One study of guaifenesin showed benefit over placebo in reducing cough frequency; another one showed no benefit over placebo.
Vitamin C, echinacea. Three Cochrane reviews found no conclusive evidence of benefit over placebo for either vitamin C11 or echinacea12 in treating the common cold.
Zinc. A new panel has been convened by the Cochrane group to reassess the effectiveness of zinc, but a 1999 Cochrane review13 found no benefit for zinc over placebo.
Antihistamines are not effective for relieving cold symptoms.14
Pseudoephedrine is the only medication with good-quality evidence for effectiveness, but only for reducing nasal symptoms.15 The authors concluded that patients may be encouraged to continue pseudoephedrine for up to 5 days if found to be effective with the first dose. Nasal congestion and discharge, however, are only 2 of the many irritating symptoms of a cold.
Bernard Ewigman, MD, MSPH
If you are in full-time clinical practice, a medical director of a practice, or otherwise directly involved in decision-making about adopting new practices, join our team of “reality checkers.”
Just email me at be.editor@gmail.com